TY - JOUR
T1 - Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain
AU - Shahidehpour, Ryan K.
AU - Higdon, Rebecca E.
AU - Crawford, Nicole G.
AU - Neltner, Janna H.
AU - Ighodaro, Eseosa T.
AU - Patel, Ela
AU - Price, Douglas
AU - Nelson, Peter T.
AU - Bachstetter, Adam D.
N1 - Publisher Copyright:
© 2020 The Author(s)
PY - 2021/3
Y1 - 2021/3
N2 - Loss of physiological microglial function may increase the propagation of neurodegenerative diseases. Cellular senescence is a hallmark of aging; thus, we hypothesized age could be a cause of dystrophic microglia. Stereological counts were done for total microglia, two microglia morphologies (hypertrophic, and dystrophic) across the human lifespan. An age-associated increase in the number of dystrophic microglia was found in the hippocampus and frontal cortex. However, the increase in dystrophic microglia was proportional to the age-related increase in the total number of microglia. Thus, aging alone does not explain the presence of dystrophic microglia. We next tested if dystrophic microglia could be a disease-associated microglia morphology. Compared to controls, the number of dystrophic microglia was greater in cases with either Alzheimer's disease, dementia with Lewy bodies, or limbic-predominant age-related TDP-43 encephalopathy (LATE). These results demonstrate that microglia dystrophy, and not hypertrophic microglia, are the disease-associated microglia morphology. Finally, we found strong evidence for iron homeostasis changes in dystrophic microglia, providing a possible molecular mechanism driving the degeneration of microglia in neurodegenerative disease.
AB - Loss of physiological microglial function may increase the propagation of neurodegenerative diseases. Cellular senescence is a hallmark of aging; thus, we hypothesized age could be a cause of dystrophic microglia. Stereological counts were done for total microglia, two microglia morphologies (hypertrophic, and dystrophic) across the human lifespan. An age-associated increase in the number of dystrophic microglia was found in the hippocampus and frontal cortex. However, the increase in dystrophic microglia was proportional to the age-related increase in the total number of microglia. Thus, aging alone does not explain the presence of dystrophic microglia. We next tested if dystrophic microglia could be a disease-associated microglia morphology. Compared to controls, the number of dystrophic microglia was greater in cases with either Alzheimer's disease, dementia with Lewy bodies, or limbic-predominant age-related TDP-43 encephalopathy (LATE). These results demonstrate that microglia dystrophy, and not hypertrophic microglia, are the disease-associated microglia morphology. Finally, we found strong evidence for iron homeostasis changes in dystrophic microglia, providing a possible molecular mechanism driving the degeneration of microglia in neurodegenerative disease.
KW - Aging
KW - microglia morphology
KW - neurodegeneration
KW - neuroinflammation
KW - neuropathology
KW - senescence
UR - http://www.scopus.com/inward/record.url?scp=85102218844&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102218844&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2020.12.003
DO - 10.1016/j.neurobiolaging.2020.12.003
M3 - Article
C2 - 33422891
AN - SCOPUS:85102218844
SN - 0197-4580
VL - 99
SP - 19
EP - 27
JO - Neurobiology of Aging
JF - Neurobiology of Aging
ER -